Patients with mutations in the F8 gene, encoding coagulation protein factor VIII (FVIII), have an X-linked bleeding disorder known as hemophilia A (HemA) and lack FVIII or functional FVIII protein (1, 2). This evidence concerns the gene F8 and hemorrhagic disease.